Cite
APA Citation
Pohlmeyer, C., Cui, Z., Han, P., Clarke, A., Jones, R., Mollova, N., Mikaelian, I., Zaboli, S., Shauf, A., & Di Paolo, J. (n.d.). aB0484 Monotherapy with filgotinib, a jak1-selective inhibitor, reduces disease severity and alters immune cell subsets in the nzb/w f1 murine model of lupus. Annals of the rheumatic diseases, 77, 1403. http://access.bl.uk/ark:/81055/vdc_100144712509.0x000053